Literature DB >> 27788588

Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virus.

Abdel Hady A Abdel Wahab1, Medhat S El-Halawany2, Ahmad A Emam1, Ammar Elfiky1, Zakaria Y Abd Elmageed3.   

Abstract

CONTEXT: The incidence rate of hepatocellular carcinoma (HCC) is higher in developing countries, and most cases are associated with chronic hepatitis C virus (HCV) infection.
OBJECTIVE: To evaluate the circulating proteins as liver biomarkers for the identification of HCC associated with HCV infection in Egyptian patients using LC-MS/MS analysis.
METHODS: Blood sera were collected from 31 HCC patients and the fractionated proteins were subjected to LC-MS/MS analysis. Protein candidates were validated by enzyme-linked immunosorbent assay (ELISA).
RESULTS: Thirty-three proteins were significantly identified in the sera of HCC patients with persistent HCV infection. These proteins are involved in several biological processes including acute phase response, complement activation, hemostasis process and lipid metabolism. The level of lectin galactoside-binding soluble 3 binding protein (LGALS3BP), Kininogen-1 (KNG1), serum amyloid A2 (SAA2) and paraoxonase 1 (PON1) and alpha-fetoprtoein (AFP) were elevated in serum.
CONCLUSION: In HCC patients with chronic HCV infection, we identified a group of differentially expressed circulating proteins involved in regulating different cellular mechanisms.

Entities:  

Keywords:  AFP; HCC; LC-MS/MS; protein biomarkers; specificity and sensitivity

Mesh:

Substances:

Year:  2016        PMID: 27788588     DOI: 10.1080/1354750X.2016.1252966

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  5 in total

1.  Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival.

Authors:  Zheng Yu; Qifeng Ou; Fan Chen; Jiong Bi; Wen Li; Jieyi Ma; Rongchang Wang; Xiaohui Huang
Journal:  J Transl Med       Date:  2018-11-26       Impact factor: 5.531

Review 2.  The Prospect and Challenges to the Flow of Liquid Biopsy in Africa.

Authors:  Dada Oluwaseyi Temilola; Martha Wium; Tangbadioa Herve Coulidiati; Henry Ademola Adeola; Giuseppina Maria Carbone; Carlo Vittorio Catapano; Luiz Fernando Zerbini
Journal:  Cells       Date:  2019-08-09       Impact factor: 6.600

3.  Synergistic Effect of Benzethonium Chloride Combined with Endoxan against Hepatocellular Carcinoma in Rats through Targeting Apoptosis Signaling Pathway.

Authors:  Omayma A R Abozaid; Fatma S M Moawed; Mostafa A Farrag; Ragaa S M Kawara
Journal:  Asian Pac J Cancer Prev       Date:  2020-06-01

4.  Identification of key pathways and biomarkers in sorafenib-resistant hepatocellular carcinoma using bioinformatics analysis.

Authors:  Danping Huang; Weiqu Yuan; Hanmin Li; Shaodong Li; Zuanguang Chen; Hongzhi Yang
Journal:  Exp Ther Med       Date:  2018-07-09       Impact factor: 2.447

5.  Proteomic analysis revealed common, unique and systemic signatures in gender-dependent hepatocarcinogenesis.

Authors:  Huiling Li; Zhuona Rong; Hong Wang; Nan Zhang; Chunwen Pu; Yi Zhao; Xu Zheng; Chuanyi Lei; Yang Liu; Xiaoqin Luo; Jun Chen; Fujin Wang; Aiguo Wang; Jingyu Wang
Journal:  Biol Sex Differ       Date:  2020-08-13       Impact factor: 5.027

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.